Lista de obras - Yoon-Sim Yap - Dominio Público Uruguay

1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers

artículo científico publicado en 2020

A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer

artículo científico publicado en 2006

A preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometry

artículo científico publicado en 2017

Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines

scientific article published on 01 June 2006

Assessment of PARP4 as a candidate breast cancer susceptibility gene

artículo científico publicado en 2019

Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.

artículo científico publicado en 2016

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

artículo científico publicado en 2012

Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study

artículo científico publicado en 2015

BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy

artículo científico publicado en 2019

Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival ⬇️

artículo científico publicado el 23 de agosto de 2012

Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer

artículo científico publicado en 2015

Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype

artículo científico publicado en 2018

Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation

article

Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence.

artículo científico publicado en 2017

Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer--how low can you go?

scientific article published on 26 March 2007

Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT

artículo científico publicado en 2012

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

scientific article published on 01 December 2019

Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform

scientific article published on 25 September 2019

Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors

artículo científico publicado en 2018

Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.

artículo científico publicado en 2012

Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers

artículo científico publicado en 2018

Evaluation of nanofluidics technology for high-throughput SNP genotyping in a clinical setting

artículo científico publicado en 2011

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.

artículo científico publicado en 2018

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer

artículo científico publicado en 2021

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.

artículo científico publicado en 2017

Identification of Novel Breast Cancer Risk Loci.

artículo científico

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

artículo científico publicado en 2011

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.

artículo científico publicado en 2016

Insights Into Breast Cancer in the East vs the West: A Review

scientific article published on 16 May 2019

Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

scientific article published on 04 February 2019

Lymphomatous infiltration of the peripheral nervous system in enteropathy-associated T-cell lymphoma

artículo científico publicado en 2005

Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients.

artículo científico publicado en 2011

Measurement properties of the eight-item abbreviated functional assessment of cancer therapy--breast symptom index and comparison with its 37-item parent measure.

artículo científico publicado en 2012

Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.

artículo científico publicado en 2014

Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer

scientific article published on 29 May 2019

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients ⬇️

artículo científico publicado en 2016

PI3K/Akt/mTOR inhibitors in breast cancer

artículo científico publicado en 2015

Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide

artículo científico publicado en 2016

Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice

artículo científico publicado en 2019

Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population.

artículo científico publicado en 2015

Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.

artículo científico publicado en 2017

Reducing the risk of peripherally inserted central catheter line complications in the oncology setting.

artículo científico publicado en 2006

Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy

artículo científico publicado en 2018

Response to Sung, Rosenberg, and Yang

artículo científico publicado en 2019

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

artículo científico publicado en 2016

The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients ⬇️

artículo científico publicado el 6 de junio de 2012

Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

scientific article published on 04 July 2019

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

artículo científico publicado en 2019

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

artículo científico publicado en 2018

Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer

scientific article published on 27 March 2019

Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting

artículo científico publicado en 2018

Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.

artículo científico publicado en 2015

Lista de obras de Yoon-Sim Yap

1Phase I trial of expanded, activated autologous NK cell infusions with trastuzumab in patients with HER2-positive cancers

A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer

A preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometry

Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines

Assessment of PARP4 as a candidate breast cancer susceptibility gene

Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study

BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy

Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival ⬇️

Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer

Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype

Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation

Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence.

Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer--how low can you go?

Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT

Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population

Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform

Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors

Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.

Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers

Evaluation of nanofluidics technology for high-throughput SNP genotyping in a clinical setting

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.

Identification of Novel Breast Cancer Risk Loci.

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore.

Insights Into Breast Cancer in the East vs the West: A Review

Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

Lymphomatous infiltration of the peripheral nervous system in enteropathy-associated T-cell lymphoma

Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients.

Measurement properties of the eight-item abbreviated functional assessment of cancer therapy--breast symptom index and comparison with its 37-item parent measure.

Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patients.

Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients ⬇️

PI3K/Akt/mTOR inhibitors in breast cancer

Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide

Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice

Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population.

Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.

Reducing the risk of peripherally inserted central catheter line complications in the oncology setting.

Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy

Response to Sung, Rosenberg, and Yang

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients ⬇️

Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.

Validation of a Risk Score Incorporating Tumor Characteristics into the American Joint Committee on Cancer Anatomic Stage for Breast Cancer

Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting

Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.